Sagrada Familia
Open Gallery
2nd Euro Global Summit on
Infectious Diseases and Microbiology
Barcelona, Spain | November 03-05, 2025
About Clinical Microbiology and
Infectious Diseases:
Welcome to the “Euro Global
Summit on Infectious Diseases and Microbiology”. held during November 03-05, 2025 at Barcelona, Spain. We are thrilled to
have you join us for this informative and engaging event.
Theme: “Promulgating innovations in Infectious
Diseases”
The purpose of Clinical Microbiology and Infectious Diseases 2025 is
to bring together professionals from around the world to share knowledge and
best practices in the field. Our goal is to keep attendees up to date on the
latest research, advancements, and techniques in clinical microbiology and
infectious diseases through November
03-05, 2025. The conference features a diverse range of topics, from
advancements in microbial identification and antimicrobial therapy to emerging
infectious diseases and infection control strategies. Our expert speakers will
share their expertise and experiences, allowing attendees to learn from and
engage with them. We understand that attending conferences can be a busy and
overwhelming experience, which is why we have created a welcoming and inclusive
environment for all attendees.
Why to attend?
Attending the “Euro Global
Summit on Infectious Diseases and Microbiology” in Barcelona, Spain on November
03-05, 2025 offers a unique platform for professionals, researchers, and
practitioners to come together and exchange knowledge, insights, and
experiences in the field. It provides an unparalleled opportunity to stay
abreast of the latest advancements, breakthroughs, and trends in clinical
microbiology and infectious diseases. By networking with leading experts and
peers from around the world, attendees can foster collaborations, gain new
perspectives, and explore potential research collaborations or partnerships.
Moreover, presenting research findings or innovations allows individuals to
showcase their contributions to the field and receive valuable feedback.
Overall, participation in this conference not only enriches professional
development but also contributes to the collective effort to address global
health challenges related to infectious diseases.
Who will be the participants?
Academic Deans and Directors | Professors and Project Leads | Postdocs
and Research Scholars | Young Scientists and Students | CEOs/ CFOs/ Chairs/
Vice-Chairs | Marketing/ Business and Development Teams | Experts who are
keen-sighted for Collaboration | Product Designers and Resolution Workers |
Business Sales & Services Professionals | Associations and Society Members
| Funding Organizations & Fundraisers.
Clinical Microbiology
Viral Infectious Diseases
Infectious Diseases
Environmental Microbiology
Vaccines and Vaccination
Microbiome and Health
Microbiology and Virology
Microbiology Research and Advancements
Immunization and Vaccine Development
Infection Prevention and Control
Bacterial Infections
Therapeutic Advances in Infectious Diseases
Antimicrobial Resistance
Coronavirus Disease (COVID-19)
Food Microbiology and Food Borne Diseases
Public Health & Diseases
Bioinformatics and Computational Microbiology
Epidemiological Diseases
Bacterial/Viral/Fungal Infectious Diseases
Immunity & Vaccination
Pharmaceutical Microbiology
Causes & Symptoms of Infectious Diseases
Pediatric/Childhood Infectious Diseases
Pathogenicity of Microbes
Infection Prevention, Control and Cure
Antimicrobial/Antibiotics/Antibacterial
Infection Prevention and Control
Antibiotic Alternatives and Antimicrobial Stewardship
Veterinary Infectious Diseases
Marine Microbiology
Infectious Diseases Market Analysis and
Size:
The infectious
disease market, particularly concerning bacterial infections, is witnessing a
surge in demand for rapid diagnostics and effective treatments due to the rise
of antibiotic-resistant strains. Companies such as Cepheid and Tetraphase
Pharmaceuticals are capitalizing on this trend by developing innovative testing
platforms and novel antibiotics, respectively. This reflects a growing market
need for advanced solutions to combat bacterial infections, driving investment
and innovation in the field.
Global infectious diseases market size was valued at USD 20.52 billion in 2023 and is projected to reach USD 32.14 billion by 2031, with a CAGR of 5.77 % during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Microbiology Testing Market Analysis and Size:
An
increasing number of aerobic and anaerobic tests are creating the way for the
growth of microbiology testing. As per WHO, around 7 million people get
infected by influenza in the U.S. every year. This creates a huge scope of
growth for research and development proficiencies associated with microbiology
testing. Several new government policies in enhancing the diagnostic and
testing processes will ultimately lead to the growth of microbiology testing as
it is an important component in testing viruses.
Data
Bridge Market Research analyses that the microbiology testing market, which was
USD 4.61 billion in 2022, would rise to USD 9.26 billion by 2030 and is
expected to undergo a CAGR of 9.1% during the forecast period from 2023 to
2030. In addition to the insights on market scenarios such as market value,
growth rate, segmentation, geographical coverage, and major players, the market
reports curated by the Data Bridge Market Research also include depth expert
analysis, patient epidemiology, pipeline analysis, pricing analysis, and
regulatory framework.
Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call
egsidm@apexglobalmeetings.com
